Literature DB >> 15348289

Adsorption of vascular endothelial growth factor to two different apatitic materials and its release.

V Midy1, E Hollande, C Rey, M Dard, J Plouët.   

Abstract

The aim of our study was to assess the ability of calcium phosphate powders to serve as growth factor carriers. Vascular endothelial growth factor (VEGF), in particular, is locally involved in the bone formation process throughout osteoblast differentiation. Two different apatitic substrates were tested: hydroxyapatite (HA), widely used as biomaterial, and nanocrystalline carbonated apatite (CA), which has a composition similar to bone mineral crystals. These materials have been compared for their VEGF adsorption and release properties. The adsorption of the growth factor was higher on CA than on HA probably due to differences of both the proteins and the powders involved. The specific activity of the VEGF released was also tested to determine the available activity for cells in contact with these materials. Interestingly, the bioactivity of the VEGF released from CA quantified on fetal bovine aortic endothelial cells (FBAE) by evaluating the proliferation activity, exhibited no marked difference compared to native VEGF. Qualitatively, VEGF adsorbed on CA material induced well-defined collagen type I immunostaining on osteoblast cells compared to the staining obtained after VEGF adsorption on HA. Copyright 2001 Kluwer Academic Publishers

Entities:  

Year:  2001        PMID: 15348289     DOI: 10.1023/a:1011286818733

Source DB:  PubMed          Journal:  J Mater Sci Mater Med        ISSN: 0957-4530            Impact factor:   3.896


  24 in total

1.  Desorption of protein and bacteria from hydroxyapatite by fluoride and monofluorophosphate.

Authors:  G Rölla; B Melsen
Journal:  Caries Res       Date:  1975       Impact factor: 4.056

2.  Cultured bovine bone cells synthesize basic fibroblast growth factor and store it in their extracellular matrix.

Authors:  R K Globus; J Plouet; D Gospodarowicz
Journal:  Endocrinology       Date:  1989-03       Impact factor: 4.736

Review 3.  Cellular and molecular events during embryonic bone development.

Authors:  S P Bruder; A I Caplan
Journal:  Connect Tissue Res       Date:  1989       Impact factor: 3.417

4.  Effect of carbonate on the lattice parameters of apatite.

Authors:  R Zapanta-LeGeros
Journal:  Nature       Date:  1965-04-24       Impact factor: 49.962

5.  Purification, characterization, and biological properties of the eye-derived growth factor from retina: analogies with brain-derived growth factor.

Authors:  D Barritault; J Plouët; J Courty; Y Courtois
Journal:  J Neurosci Res       Date:  1982       Impact factor: 4.164

6.  Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells.

Authors:  N Ferrara; W J Henzel
Journal:  Biochem Biophys Res Commun       Date:  1989-06-15       Impact factor: 3.575

7.  Induction of vascular endothelial growth factor expression by prostaglandin E2 and E1 in osteoblasts.

Authors:  S Harada; J A Nagy; K A Sullivan; K A Thomas; N Endo; G A Rodan; S B Rodan
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

8.  Preparation, analysis, and characterization of carbonated apatites.

Authors:  D G Nelson; J D Featherstone
Journal:  Calcif Tissue Int       Date:  1982       Impact factor: 4.333

Review 9.  Control of vascular endothelial growth factor angiogenic activity by the extracellular matrix.

Authors:  N Ortéga; F E L'Faqihi; J Plouët
Journal:  Biol Cell       Date:  1998-09       Impact factor: 4.458

10.  Basic fibroblast growth factor adsorption and release properties of calcium phosphate.

Authors:  V Midy; C Rey; E Bres; M Dard
Journal:  J Biomed Mater Res       Date:  1998-09-05
View more
  4 in total

1.  Self-setting calcium orthophosphate formulations.

Authors:  Sergey V Dorozhkin
Journal:  J Funct Biomater       Date:  2013-11-12

2.  Adsorption on apatitic calcium phosphates for drug delivery: interaction with bisphosphonate molecules.

Authors:  P Pascaud; F Errassifi; F Brouillet; S Sarda; A Barroug; A Legrouri; C Rey
Journal:  J Mater Sci Mater Med       Date:  2014-05-01       Impact factor: 3.896

3.  Novel factor-loaded polyphosphazene matrices: potential for driving angiogenesis.

Authors:  Olugbemisola Oredein-McCoy; Nicholas R Krogman; Arlin L Weikel; Mark D Hindenlang; Harry R Allcock; Cato T Laurencin
Journal:  J Microencapsul       Date:  2009-09       Impact factor: 3.142

4.  Biocompatibility of Poly-epsilon-caprolactone-hydroxyapatite composite on mouse bone marrow-derived osteoblasts and endothelial cells.

Authors:  Haiying Yu; Paul H Wooley; Shang-You Yang
Journal:  J Orthop Surg Res       Date:  2009-02-26       Impact factor: 2.359

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.